Michal Sheffer

5.4k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Michal Sheffer is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Michal Sheffer has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Michal Sheffer's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers) and Immune Cell Function and Interaction (5 papers). Michal Sheffer is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers) and Immune Cell Function and Interaction (5 papers). Michal Sheffer collaborates with scholars based in United States, Israel and Finland. Michal Sheffer's co-authors include Eytan Domany, Uri Alon, Inbal Ayzenshtat, Shalev Itzkovitz, Nadav Kashtan, Shai S. Shen-Orr, Ron Milo, Yotam Drier, Francis Barany and Daniel A. Notterman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Michal Sheffer

29 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Superfamilies of Evolved and Designed Networks

2004 962 citations Michal Sheffer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Sheffer United States	13	1.4k	466	434	418	266	31	2.4k
Lin Yuan China	29	1.7k 1.2×	550 1.2×	128 0.3×	1.1k 2.6×	93 0.3×	145	2.7k
Duygu Ucar United States	25	1.9k 1.4×	321 0.7×	146 0.3×	219 0.5×	351 1.3×	55	3.1k
Radu Dobrin Sweden	22	1.6k 1.1×	161 0.3×	199 0.5×	179 0.4×	135 0.5×	82	2.8k
Carl Herrmann Germany	24	1.5k 1.1×	126 0.3×	258 0.6×	334 0.8×	357 1.3×	56	2.4k
Sven Bilke United States	29	1.8k 1.3×	86 0.2×	531 1.2×	703 1.7×	200 0.8×	68	2.6k
Jianhua Ruan United States	25	1.5k 1.1×	235 0.5×	123 0.3×	299 0.7×	116 0.4×	81	2.3k
Sylvain Brohée Belgium	19	1.8k 1.3×	65 0.1×	1.1k 2.4×	612 1.5×	346 1.3×	27	3.0k
Xianghong Jasmine Zhou United States	35	3.7k 2.7×	115 0.2×	208 0.5×	1.1k 2.6×	299 1.1×	88	4.7k
C. Stark Canada	6	3.6k 2.6×	249 0.5×	144 0.3×	197 0.5×	158 0.6×	7	4.3k
Joshua J. Waterfall United States	19	3.2k 2.4×	65 0.1×	289 0.7×	627 1.5×	369 1.4×	33	4.2k

Countries citing papers authored by Michal Sheffer

Since Specialization

Citations

This map shows the geographic impact of Michal Sheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Sheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Sheffer more than expected).

Fields of papers citing papers by Michal Sheffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Sheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Sheffer. The network helps show where Michal Sheffer may publish in the future.

Co-authorship network of co-authors of Michal Sheffer

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Sheffer. A scholar is included among the top collaborators of Michal Sheffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Sheffer. Michal Sheffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Alaa Kassim, et al.. (2024). An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells. Journal for ImmunoTherapy of Cancer. 12(5). e008912–e008912. 4 indexed citations

Jang, Ji Eun, Maja Stanojević, Michal Sheffer, et al.. (2024). Mesothelin Targeting IL12-Engineered CAR Memory-like NK Cells Demonstrate Promising Efficacy in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 917–917. 4 indexed citations

Gandolfi, Sara, Olli Dufva, Jani Huuhtanen, et al.. (2021). Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma. Blood. 138(Supplement 1). 732–732. 2 indexed citations

Dashevsky, Olga, Ricardo De Matos Simoes, Benjamin G. Barwick, et al.. (2021). Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma. Blood. 138(Supplement 1). 1612–1612.

Dashevsky, Olga, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2020). Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms. Blood. 136(Supplement 1). 36–36.

Gandolfi, Sara, Michal Sheffer, Olga Dashevsky, et al.. (2019). Molecular markers of MM cell sensitivity and resistance to Natural Killer cells: implications for anti-MM immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e168–e169. 1 indexed citations

Dufva, Olli, Khalid Saeed, Sara Gandolfi, et al.. (2019). CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers. Blood. 134(Supplement_1). 3597–3597. 3 indexed citations

Tang, Huihui, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2018). CRISPR Activation Screen for HDAC Inhibitor Resistance. Blood. 132(Supplement 1). 3958–3958. 1 indexed citations

Gandolfi, Sara, Olga Dashevsky, Ricardo De Matos Simoes, et al.. (2017). Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens. Blood. 130. 3028–3028. 1 indexed citations

10.

Ron‐Harel, Noga, Daniel Santos, Jonathan M. Ghergurovich, et al.. (2016). Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. Cell Metabolism. 24(1). 104–117. 301 indexed citations

11.

Matthews, Geoffrey M., Ricardo De Matos Simoes, Eugen Dhimolea, et al.. (2016). NF-κB dysregulation in multiple myeloma. Seminars in Cancer Biology. 39. 68–76. 43 indexed citations

12.

Matthews, Geoffrey M., Sara Gandolfi, Ricardo De Matos Simoes, et al.. (2016). BET Bromodomain Degradation As a Therapeutic Strategy in Multiple Myeloma. Blood. 128(22). 1062–1062. 3 indexed citations

13.

Bublik, Débora Rosa, Slađana Bursać, Michal Sheffer, et al.. (2016). Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proceedings of the National Academy of Sciences. 114(4). E496–E505. 55 indexed citations

14.

Kim, Sun-Hee, Dingzhi Wang, Yun‐Yong Park, et al.. (2013). HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Cancer Letters. 341(2). 159–165. 21 indexed citations

15.

Drier, Yotam, Michal Sheffer, & Eytan Domany. (2013). Pathway-based personalized analysis of cancer. Proceedings of the National Academy of Sciences. 110(16). 6388–6393. 232 indexed citations

16.

Sheffer, Michal, Jasmine Jacob‐Hirsch, Valentina Folgiero, et al.. (2012). HIPK2 downregulates vimentin and inhibits breast cancer cell invasion. Cancer Biology & Therapy. 13(4). 198–205. 30 indexed citations

17.

Sagiv, Eyal, Michal Sheffer, Diana Kazanov, et al.. (2011). Gene Expression following Exposure to Celecoxib in Humans: Pathways of Inflammation and Carcinogenesis Are Activated in Tumors but Not Normal Tissues. Digestion. 84(3). 169–184. 3 indexed citations

18.

Sagiv, Eyal, Michal Sheffer, Diana Kazanov, et al.. (2009). S1971 Celecoxib Selectively Targets Genes and Pathways Involved in Inflammation and Malignant Transformation in Tumor But Not Normal Cells. Gastroenterology. 136(5). A–304. 1 indexed citations

19.

Gavert, Nancy, Michal Sheffer, Shani Raveh, et al.. (2007). Expression of L1-CAM and ADAM10 in Human Colon Cancer Cells Induces Metastasis. Cancer Research. 67(16). 7703–7712. 167 indexed citations

20.

Rosty, Christophe, Michal Sheffer, Dafna Tsafrir, et al.. (2005). Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene. 24(47). 7094–7104. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact